Related references
Note: Only part of the references are listed.Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction
Jean-Claude Tardif et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
The long-term prognostic significance of sarcoidosis-associated pulmonary hypertension A cohort study
Shmuel Tiosano et al.
CLINICAL IMMUNOLOGY (2019)
Epilepsy among Systemic Lupus Erythematosus Patients: Insights from a Large Database Analysis
Abdulla Watad et al.
NEUROEPIDEMIOLOGY (2018)
Ischemic heart disease and ankylosing spondylitis-assessing the role of inflammation
Michal Vinker Shuster et al.
CLINICAL RHEUMATOLOGY (2018)
Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome A CT Coronary Angiography Study
Kaivan Vaidya et al.
JACC-CARDIOVASCULAR IMAGING (2018)
Smoking and obesity in systemic lupus erythematosus: a cross-sectional study
Mathilde Versini et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Familial Mediterranean fever gene mutations as a risk factor for early coronary artery disease
Nurcan Basar et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2017)
Familial Mediterranean fever, review of the literature
Mansour Alghamdi
CLINICAL RHEUMATOLOGY (2017)
EULAR recommendations for the management of familial Mediterranean fever
Seza Ozen et al.
ANNALS OF THE RHEUMATIC DISEASES (2016)
The Relationship between NALP3 and Autoinflammatory Syndromes
Lorna Campbell et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)
Atherosclerosis in rheumatoid arthritis: is it all about inflammation?
Sarah Skeoch et al.
NATURE REVIEWS RHEUMATOLOGY (2015)
Compliance to colchicine treatment and disease activity in Familial Mediterranean Fever (FMF) patients in Middle/Black Sea Region of Turkey (in Çorum region)
Y Karaaslan et al.
Pediatric Rheumatology (2015)
Mortality risk factors associated with familial Mediterranean fever among a cohort of 1.25 million adolescents
Gilad Twig et al.
ANNALS OF THE RHEUMATIC DISEASES (2014)
Atherosclerosis in Systemic Lupus Erythematosus
George Stojan et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2013)
Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease
Stefan M. Nidorf et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Colchicine Treatment for the Prevention of Bare-Metal Stent Restenosis in Diabetic Patients
Spyridon Deftereos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Inflammation in Atherosclerosis
Peter Libby
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Chronic inflammation in FmF: markers, risk factors, outcomes and therapy
Ilan Ben-Zvi et al.
NATURE REVIEWS RHEUMATOLOGY (2011)
Role of inflammation in atherosclerosis associated with rheumatoid arthritis
Peter Libby
AMERICAN JOURNAL OF MEDICINE (2008)
Impaired coronary microvascular function in familial Mediterranean fever
Mustafa Caliskan et al.
ATHEROSCLEROSIS (2007)
Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with stable coronary artery disease
Mark Nidorf et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Early ultrasonographic markers of atherosclerosis in patients with familial Mediterranean fever
Ismail Sari et al.
CLINICAL RHEUMATOLOGY (2007)
Are familial Mediterranean fever (IMF) patients at increased risk for atherosclerosis? Impaired endothelial function and increased intima media thickness are found in IMF
Ali Akdogan et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Role of the pyrin M694V (A2080G) allele in acute myocardial infarction and longevity: a study in the Sicilian population
Maria Paola Grimaldi et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2006)
Inflammation and atherosclerosis
P Libby et al.
CIRCULATION (2002)
The spectrum of Familial Mediterranean Fever (FMF) mutations
I Touitou
EUROPEAN JOURNAL OF HUMAN GENETICS (2001)